A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the nasal anti-CD3 in a mouse model of TBI, researchers found the spray could reduce damage to the central nervous system and behavioral deficits, suggesting a potential therapeutic approach for TBI and other acute forms of brain injury.
Quelle: ScienceDaily | Immunsystem
Titelbild/Grafik: ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- Recently discovered immune cell type is key to understanding food allergies
- New immune boost could expand access to cancer immunotherapy
- Immune protein modification blocks viral replication, heart inflammation
- New phase of the immune response uncovered
- Study shows how new antibody therapy works against ovarian cancer
- FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy
- Advanced imaging reveals mechanisms that cause autoimmune disease
- Master regulator blocking immunotherapy, paving the way for a new lung cancer treatment
- Potential Alzheimer's disease therapeutic target identified in brain immune cells
- Setback in gene therapy for Duchenne muscular dystrophy as immune system emerges as key barrier
